TY - JOUR
T1 - COPD
T2 - Providing the right treatment for the right patient at the right time
AU - Agusti, Alvar
AU - Ambrosino, Nicolino
AU - Blackstock, Felicity
AU - Bourbeau, Jean
AU - Casaburi, Richard
AU - Celli, Bartolome
AU - Crouch, Rebecca
AU - Negro, Roberto Dal
AU - Dreher, Michael
AU - Garvey, Christine
AU - Gerardi, Daniel
AU - Goldstein, Roger
AU - Hanania, Nicola
AU - Holland, Anne E.
AU - Kaur, Antarpreet
AU - Lareau, Suzanne
AU - Lindenauer, Peter K.
AU - Mannino, David
AU - Make, Barry
AU - Maltais, François
AU - Marciniuk, Jeffrey D.
AU - Meek, Paula
AU - Morgan, Mike
AU - Pepin, Jean Louis
AU - Reardon, Jane Z.
AU - Rochester, Carolyn
AU - Singh, Sally
AU - Spruit, Martijn A.
AU - Steiner, Michael C.
AU - Troosters, Thierry
AU - Vitacca, Michele
AU - Clini, Enico
AU - Jardim, Jose
AU - Nici, Linda
AU - Raskin, Jonathan
AU - ZuWallack, Richard
N1 - Funding Information:
A pioneer project utilizing telemedicine, supported by the Department for Public Health of the Veneto Regional Government and the National Research Council, was initiated in 1990; its general aim was to provide patients with novel therapeutic options in the home that may reduce hospitalization risk and improve quality of life. Industry and clinicians worked together to develop and refine technical support, that included exacerbation monitoring and management of long-term oxygen treatment (LTOT) for patients with severe respiratory disease.Keys to the success of CCM are effective clinical information systems to enable learning and continuous improvement, health care delivery redesign and decision support, and adequate community resources. CCM's can be facilitated by the availability of PR programs, which contain many of the essential components. Models to manage chronic respiratory disease have been encouraging in several jurisdictions, including the UK [312], the European Union [313] and Canada [314]. A recent ATS workshop on integrated care of the COPD patient encourages research, development, and implementation of this approach, including guidelines for the multi-morbid COPD patient, large randomized controlled trials of integrated care, and development of information technologies and increased community resources for education, exercise, and social support [315].
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2023/2
Y1 - 2023/2
N2 - Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable. However, a major challenge in recognizing, preventing, and treating COPD is understanding its complexity. While COPD has historically been characterized as a disease defined by airflow limitation, we now understand it as a multi-component disease with many clinical phenotypes, systemic manifestations, and associated co-morbidities. Evidence is rapidly emerging in our understanding of the many factors that contribute to the pathogenesis of COPD and the identification of “early” or “pre-COPD” which should provide exciting opportunities for early treatment and disease modification. In addition to breakthroughs in our understanding of the origins of COPD, we are optimizing treatment strategies and delivery of care that are showing impressive benefits in patient-centered outcomes and healthcare utilization. This special issue of Respiratory Medicine, “COPD: Providing the Right Treatment for the Right Patient at the Right Time” is a summary of the proceedings of a conference held in Stresa, Italy in April 2022 that brought together international experts to discuss emerging evidence in COPD and Pulmonary Rehabilitation in honor of a distinguished friend and colleague, Claudio Ferdinando Donor (1948–2021). Claudio was a true pioneer in the field of pulmonary rehabilitation and the comprehensive care of individuals with COPD. He held numerous leadership roles in in the field, provide editorial stewardship of several respiratory journals, authored numerous papers, statement and guidelines in COPD and Pulmonary Rehabilitation, and provided mentorship to many in our field. Claudio's most impressive talent was his ability to organize spectacular conferences and symposia that highlighted cutting edge science and clinical medicine. It is in this spirit that this conference was conceived and planned. These proceedings are divided into 4 sections which highlight crucial areas in the field of COPD: (1) New concepts in COPD pathogenesis; (2) Enhancing outcomes in COPD; (3) Non-pharmacologic management of COPD; and (4) Optimizing delivery of care for COPD. These presentations summarize the newest evidence in the field and capture lively discussion on the exciting future of treating this prevalent and impactful disease. We thank each of the authors for their participation and applaud their efforts toward pushing the envelope in our understanding of COPD and optimizing care for these patients. We believe that this edition is a most fitting tribute to a dear colleague and friend and will prove useful to students, clinicians, and researchers as they continually strive to provide the right treatment for the right patient at the right time. It has been our pleasure and a distinct honor to serve as editors and oversee such wonderful scholarly work.
AB - Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable. However, a major challenge in recognizing, preventing, and treating COPD is understanding its complexity. While COPD has historically been characterized as a disease defined by airflow limitation, we now understand it as a multi-component disease with many clinical phenotypes, systemic manifestations, and associated co-morbidities. Evidence is rapidly emerging in our understanding of the many factors that contribute to the pathogenesis of COPD and the identification of “early” or “pre-COPD” which should provide exciting opportunities for early treatment and disease modification. In addition to breakthroughs in our understanding of the origins of COPD, we are optimizing treatment strategies and delivery of care that are showing impressive benefits in patient-centered outcomes and healthcare utilization. This special issue of Respiratory Medicine, “COPD: Providing the Right Treatment for the Right Patient at the Right Time” is a summary of the proceedings of a conference held in Stresa, Italy in April 2022 that brought together international experts to discuss emerging evidence in COPD and Pulmonary Rehabilitation in honor of a distinguished friend and colleague, Claudio Ferdinando Donor (1948–2021). Claudio was a true pioneer in the field of pulmonary rehabilitation and the comprehensive care of individuals with COPD. He held numerous leadership roles in in the field, provide editorial stewardship of several respiratory journals, authored numerous papers, statement and guidelines in COPD and Pulmonary Rehabilitation, and provided mentorship to many in our field. Claudio's most impressive talent was his ability to organize spectacular conferences and symposia that highlighted cutting edge science and clinical medicine. It is in this spirit that this conference was conceived and planned. These proceedings are divided into 4 sections which highlight crucial areas in the field of COPD: (1) New concepts in COPD pathogenesis; (2) Enhancing outcomes in COPD; (3) Non-pharmacologic management of COPD; and (4) Optimizing delivery of care for COPD. These presentations summarize the newest evidence in the field and capture lively discussion on the exciting future of treating this prevalent and impactful disease. We thank each of the authors for their participation and applaud their efforts toward pushing the envelope in our understanding of COPD and optimizing care for these patients. We believe that this edition is a most fitting tribute to a dear colleague and friend and will prove useful to students, clinicians, and researchers as they continually strive to provide the right treatment for the right patient at the right time. It has been our pleasure and a distinct honor to serve as editors and oversee such wonderful scholarly work.
UR - http://www.scopus.com/inward/record.url?scp=85147834068&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2022.107041
DO - 10.1016/j.rmed.2022.107041
M3 - Review article
C2 - 36610384
AN - SCOPUS:85147834068
SN - 0954-6111
VL - 207
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 107041
ER -